相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
Fanny Mochel et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening
Peter Man-Un Ung et al.
ACS CHEMICAL BIOLOGY (2016)
Identification of novel GLUT inhibitors
Holger Siebeneicher et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer
Meng Wu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides
Khyati Kapoor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
Li Yu et al.
ONCOTARGET (2016)
Salicylketoximes That Target Glucose Transporter1 Restrict Energy Supply to Lung Cancer Cells
Carlotta Granchi et al.
CHEMMEDCHEM (2015)
Melatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer
David Hevia et al.
JOURNAL OF PINEAL RESEARCH (2015)
Xanthohumol impairs glucose uptake by a human first-trimester extravillous trophoblast cell line (HTR-8/SVneo cells) and impacts the process of placentation
Ana Correia-Branco et al.
MOLECULAR HUMAN REPRODUCTION (2015)
Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1
Jin Fang et al.
MOLECULAR MEDICINE REPORTS (2015)
The Chemopreventive Effect of the Dietary Compound Kaempferol on the MCF-7 Human Breast Cancer Cell Line Is Dependent on Inhibition of Glucose Cellular Uptake
Claudia Azevedo et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2015)
Inhibiting GLUT-1 expression and PI3K/Akt signaling using apigenin improves the radiosensitivity of laryngeal carcinoma in vivo
Yang-Yang Bao et al.
ONCOLOGY REPORTS (2015)
Identifying novel targets in renal cell carcinoma: Design and synthesis of affinity chromatography reagents
Muriel Bonnet et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
An update on therapeutic opportunities offered by cancer glycolytic metabolism
Carlotta Granchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
被撤回的出版物: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells (Retracted article. See vol. 40, 2019)
I-Lu Lai et al.
CARCINOGENESIS (2014)
Regulation of GLUT Transporters by Flavonoids in Androgen-Sensitive and -Insensitive Prostate Cancer Cells
Pedro Gonzalez-Menendez et al.
ENDOCRINOLOGY (2014)
A Phase I Dose-Finding Study of Silybin Phosphatidylcholine (Milk Thistle) in Patients With Advanced Hepatocellular Carcinoma
Abby B. Siegel et al.
INTEGRATIVE CANCER THERAPIES (2014)
Constituents of an Extract of Cryptocarya rubra Housed in a Repository with Cytotoxic and Glucose Transport Inhibitory Effects
Yulin Ren et al.
JOURNAL OF NATURAL PRODUCTS (2014)
Daidzein promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and improves glucose homeostasis in Type 2 diabetic model mice
Sun Hee Cheong et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Crystal structure of the human glucose transporter GLUT1
Dong Deng et al.
NATURE (2014)
Antiartherosclerotic Effects of Plant Flavonoids
Shamala Salvamani et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Resolution of the direct interaction with and inhibition of the human GLUT1 hexose transporter by resveratrol from its effect on glucose accumulation
Monica Salas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2013)
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells
Tiziano Tuccinardi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Targeted Cancer Therapy with a 2-Deoxyglucose-Based Adriamycin Complex
Jie Cao et al.
CANCER RESEARCH (2013)
Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells
Dandan Zhang et al.
CANCER SCIENCE (2013)
Dual Targeting of the Warburg Effect with a Glucose-Conjugated Lactate Dehydrogenase Inhibitor
Emilia C. Calvaresi et al.
CHEMBIOCHEM (2013)
Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties
Pengxing Liu et al.
CHEMICAL COMMUNICATIONS (2013)
Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism
Liliana Moreira et al.
EXPERIMENTAL CELL RESEARCH (2013)
Glucose conjugation for the specific targeting and treatment of cancer
Emilia C. Calvaresi et al.
CHEMICAL SCIENCE (2013)
Noncompetitive blocking of human GLUT1 hexose transporter by methylxanthines reveals an exofacial regulatory binding site
Paola Ojeda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Graviola: A novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism
Maria P. Torres et al.
CANCER LETTERS (2012)
Anticancer Agents That Counteract Tumor Glycolysis
Carlotta Granchi et al.
CHEMMEDCHEM (2012)
Design, Synthesis, and Preliminary Biological Evaluation of 6-O-Glucose-Azomycin Adducts for Diagnosis and Therapy of Hypoxic Tumors
Piyush Kumar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
被撤回的出版物: Development of a Novel Class of Glucose Transporter Inhibitors (Retracted article. See vol. 61, pg. 5056, 2018)
Dasheng Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo
Yi Liu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Hexose Transporter GLUT1 Harbors Several Distinct Regulatory Binding Sites for Flavones and Tyrphostins
Alejandra Perez et al.
BIOCHEMISTRY (2011)
A New, Convenient Cell-Based Screening Method for Small-Molecule Glycolytic Inhibitors
Mitsuhiro Kitagawa et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2011)
A Pairwise Chemical Genetic Screen Identifies New Inhibitors of Glucose Transport
Olesya A. Ulanovskaya et al.
CHEMISTRY & BIOLOGY (2011)
Silybin and Dehydrosilybin Decrease Glucose Uptake by Inhibiting GLUT Proteins
Tianzuo Zhan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Estrogen Receptor β Ligands: Recent Advances and Biomedical Applications
Filippo Minutolo et al.
MEDICINAL RESEARCH REVIEWS (2011)
Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK
Katarzyna Zygmunt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Novel inhibitors of basal glucose transport as potential anticancer agents
Weihe Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent d-19575 (glufosfamide) in patients with solid tumors
Toshio Shimizu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms
Yi Liu et al.
CANCER LETTERS (2010)
Metabolomic Identification of the Target of the Filopodia Protrusion Inhibitor Glucopiericidin A
Mitsuhiro Kitagawa et al.
CHEMISTRY & BIOLOGY (2010)
Phenolic compounds from Cryptocarya konishii: their cytotoxic and tyrosine kinase inhibitory properties
Fera Kurniadewi et al.
JOURNAL OF NATURAL MEDICINES (2010)
Cryptocaryone, a Natural Dihydrochalcone, Induces Apoptosis in Human Androgen Independent Prostate Cancer Cells by Death Receptor Clustering in Lipid Raft and Nonraft Compartments
Yi-Cheng Chen et al.
JOURNAL OF UROLOGY (2010)
Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol
Alejandra Perez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter
Chih-Hsiung Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Structural Evolutions of Salicylaldoximes as Selective Agonists for Estrogen Receptor β
Filippo Minutolo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury
Masoumeh Akhlaghi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
Simona Ben-Haim et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK
Danna M. Breen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cells
Masaaki Nomura et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1
Shala L. Thomas et al.
CELL CYCLE (2008)
Active Compounds from Lagerstroemia speciosa, Insulin-like Glucose Uptake-Stimulatory/Inhibitory and Adipocyte Differentiation-Inhibitory Activities in 3T3-L1 Cells
Naisheng Bai et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
Differential expression of glut 1 mRNA and protein levels correlates with increased sensitivity to the glyco-conjugated nitric oxide donor (2-glu-SNAP) in different tumor cell types
P. R. Subbarayan et al.
JOURNAL OF CHEMOTHERAPY (2008)
Targeting the Delivery of Glycan-Based Paclitaxel Prodrugs to Cancer Cells via Glucose Transporters
Yih-Shyan Lin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death
Tabitha E. Wood et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Apigenin Inhibits the GLUT-1 Glucose Transporter and the Phosphoinositide 3-Kinase/Akt Pathway in Human Pancreatic Cancer Cells
Laleh G. Melstrom et al.
PANCREAS (2008)
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia
Xianhua Cao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Synthesis of 2′-paclitaxel methyl 2-glucopyranosyl succinate for specific targeted delivery to cancer cells
Der-Zen Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Inhibition of the intestinal glucose transporter GLUT2 by flavonoids
Oran Kwon et al.
FASEB JOURNAL (2007)
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients
Thomas W. Flaig et al.
INVESTIGATIONAL NEW DRUGS (2007)
Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors
AD Schimmer et al.
CANCER RESEARCH (2006)
Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes
P Strobel et al.
BIOCHEMICAL JOURNAL (2005)
EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism
BK Adams et al.
ANTI-CANCER DRUGS (2005)
Genistein directly inhibits GLUT4-mediated glucose uptake in 3T3-L1 adipocytes
M Bazuine et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation
AW Harmon et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents
BK Adams et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes
HJ Martin et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2003)
Naringenin inhibits phosphoinositide 3-kinase activity and glucose uptake in 3T3-L1 adipocytes
AW Harmon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Inhibition of glucose and dehydroascorbic acid uptakes by resveratrol in human transformed myelocytic cells
JB Park
JOURNAL OF NATURAL PRODUCTS (2001)
Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors
JC Vera et al.
BIOCHEMISTRY (2001)
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group
E Briasoulis et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
